Interventional Valve Therapy

Management:
Dr. med. habil. Marek Kowalski
Dr. med. Steffen Hofmann

Team:
Dr. med. Michael Billion
Dr. med. Klaus-Dieter Hönemann

The research focus of “Interventional valve therapy” deals with the catheter-interventional therapy of valvular heart diseases. The Schüchtermann-Klinik is one of the largest centres for interventional valve therapy in Germany and is a training centre for national and international guests.

For elderly patients in particular with a high to very high surgical risk, methods such as transcatheter aortic valve implantation (TAVI) are the therapy of choice for symptomatic aortic valve stenosis. Not only improved patient selection, more precise imaging and the use of new technologies have led to the great success of this method, but above all the interdisciplinary co-operation within the Heart Team with its continually increasing levels of experience.

The above also applies to the implantation of MitraClips in both the mitral and tricuspid position. The results available have shown that the MitraClip procedure represents a low-risk, gentle and effective alternative to conventional heart surgery for selected patients. Due to the low complication rates and the gentle intervention, the procedure is particularly suitable for patients for whom surgery represents a high risk.

Meanwhile there are also fully via catheter implantable mitral valve systems available (e.g. TIARA) which can be implanted in the Schüchtermann-Klinik Bad Rothenfelde depending on anatomical requirements and after positive consultation with the heart team.

Supervised studies and registers:

• TIARA II (Phase II / since 2019, ongoing)
• TRILUMINATE (Phase II / since 2018, ongoing)

• SOURCE3-Register (since 2014, ongoing)
• Internal-TAVI-Register (since 2008, ongoing)